June 16, 2020 article Open access TDM is dead. Long live TCI! British Journal of Clinical Pharmacology DOI: 10.1111/bcp.14434 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 4 stored of 81 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Defining the unbound target exposure of teicoplanin, Part 2: Dose individualization through population pharmacokinetic modelling 2026 Clinical Microbiology and Infection article Medicine Antibiotics Pharmacokinetics and Efficacy Open access 1 citations Should we abandon therapeutic drug monitoring of tacrolimus in whole blood and move to intracellular concentration measurements? 2023 British Journal of Clinical Pharmacology article Medicine Renal Transplantation Outcomes and Treatments Open access 19 citations The Appropriately Designed TDM Clinical Trial: Endpoints, Pitfalls, and Perspectives 2022 Therapeutic Drug Monitoring article Mathematics Statistical Methods in Clinical Trials 3 citations A prospective pilot study of a novel alemtuzumab target concentration intervention strategy 2021 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation 9 citations 4 results References 0